Company: VCYT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001384101-25-000130
Chunk: 15

Company: VERACYTE, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 15
---
 10,334 Income before income taxes18,889 16,848 27,567 22,301 Income tax (benefit) provision(248)1,693 2,363 3,276 Net income$19,137 $15,155 $25,204 $19,025 Earnings per share:Basic$0.24 $0.20 $0.32 $0.25 Diluted$0.24 $0.19 $0.32 $0.25 Shares used to compute earnings per common share:Basic78,725,139 77,013,831 78,384,184 76,107,302 Diluted79,691,703 78,464,654 79,946,386 77,339,897 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

Table of Contents

VERACYTE, INC.

 Condensed Consolidated Statements of Comprehensive Income (Loss)

 (Unaudited)

 (In thousands)

 Three Months Ended September 30,Nine Months Ended September 30, 2025202420252024Net income$19,137 $15,155 $25,204 $19,025 Other comprehensive income (loss):Change in currency translation adjustments(4,556)9,328 19,575 2,736 Release of accumulated translation adjustment8,295 — 8,295 — Other comprehensive income3,739 9,328 27,870 2,736 Net comprehensive income$22,876 $24,483 $53,074 $21,761 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

VERACYTE, INC.

Condensed Consolidated Statements of Stockholders' Equity

(Unaudited)

(In thousands)

 Common StockAdditionalPaid-inCapitalAccumulated DeficitAccumulated Other Comprehensive LossTotalStockholders'Equity SharesAmountBalance at June 30, 202578,599 $79 $1,670,853 $(437,916)$(11,959)$1,221,057 Issuance of common stock on exercise of stock options and vesting of restricted stock units363 — 4,386 — — 4,386 Issuance of common stock under employee stock purchase plan (